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Abstract
The damage to health caused by intimate partner violence demands effective responses from healthcare providers
and healthcare systems worldwide. To date, most evidence for the few existing, effective interventions in use
comes from high-income countries. Gupta et al. provide rare evidence of a nurse-delivered intimate partner
violence screening, supportive care and referral intervention from a large-scale randomised trial in Mexican public
health clinics. No difference was found in the primary outcome of reduction in intimate partner violence. There
were significant short-term benefits in safety planning and mental health (secondary outcomes) for women in the
intervention arm, but these were not sustained.
This important study highlights the challenges of primary outcome choices in such studies, and further challenges
for the sustainability of healthcare systems and healthcare provider interventions. These challenges include the role
of theory for sustainability and the risk that baseline measures of intimate partner violence can wash out
intervention effects. We emphasise the importance of studying the processes of adaptation, integration and
coordination in the context of the wider healthcare system.
Please see related article: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0880-y
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Background
Violence against women, especially intimate partner
violence (IPV), is a global pandemic. Evidence for the
range of severe health impacts has galvanised national
and international governments to include health system
reform in the suite of policy responses to this form of
violence [1]. However, to date, most of the rigorous
studies underpinning our understanding of what works,
or not, in low and middle-income (LMI) healthcare set-
tings, have originated in high-income countries [2–4].
This is problematic, as the heaviest health burden is in
LMI countries, where the capacity -whether human,
financial or logistical - is very different [3, 5, 6].
New evidence
A new study published in BMC Medicine [7] clearly
identified the gap in evidence and the barriers that exist
to conducting this form of pragmatic trial in LMI
healthcare settings. It makes a significant contribution
by illustrating the importance of and the challenges in
generating rigorous evidence.
This cluster-randomised controlled trial of 42 large
public health clinics in Mexico City [6] trained current
nurses in both arms to integrate IPV screening into a
general women’s health assessment. Nurses in the inter-
vention arm were given further training to offer a more
comprehensive response to screened women identified
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as experiencing IPV, including empathetic care, safety
planning, harm reduction counselling and supportive
referrals [6]. To those women identified as experiencing
IPV after screening, nurses in the comparison arm of-
fered a card to refer them to community-based support
services.
The primary outcome of the study was to reduce IPV
in the past year. The investigators included safety
behaviours, challenging reproductive coercion, mental
wellbeing and use of community resources as secondary
outcomes. The study measured these pre-specified
outcomes at three points, from baseline up to
15 months [6]. While there were some intermediate
improvements in mental health and safety planning be-
haviours, women in both arms of the study reported
reductions in IPV over time. The lack of a primary
treatment effect at any time offers important lessons
for overcoming challenges in IPV intervention studies
in healthcare settings.
Challenges of IPV study primary outcome choices
The study by Gupta et al. [8] raises a continuing ques-
tion in pragmatic IPV trials about the choice and level
of ambition of a primary outcome. This important study
recognised the limitations of screening and identification
strategies to increase referrals, consistent with current
high quality evidence [5, 9]. The authors’ hypothesis was
that if nurses screened, identified and counselled
women, and provided safety plans and referrals to com-
munity resources, then their partner’s violence might
decrease. However, this is likely to be out of the control
of both the women and certainly nurses. Even direct ad-
vocacy services report modest reductions in violence by
men against their partners [3]. The consistency with
which screening trials increase identification but not re-
ferral suggests that healthcare providers need additional
and repeat training, and resources to help manage those
women who are unready or unwilling to be referred [5].
Studies of women’s behaviours over the many stages of
their transition to safety [10] suggest that women’s abil-
ity to make changes depends on their self-efficacy, readi-
ness to take action and desire to leave the relationship.
Healthcare providers therefore need the skills and know-
ledge to identify a woman’s level of readiness to act, and
to be taught a range of strategies if she is unready or un-
willing to accept a referral. For many women this
process may take well over 12 months, and it may take
several years after receiving advocacy, depending on the
level of abuse [3]. Currently we have insufficient evi-
dence of effective healthcare provider training or specific
strategies to help women experiencing IPV at each of
the stages of change. The only exception to this result
has been the IRIS study conducted in England by Feder
et al. [10], in which advocates had a formal role in train-
ing and follow-up. Even so, compared with control
patient groups, the absolute numbers of referred women
in the intervention were smaller than the numbers of
affected women who would have been in the overall
patient population.
Further methodological challenges
There is also an issue of bedevilling in IPV trials.
Methodological considerations have encouraged investi-
gators to measure the baseline level of violence in both
arms of a study. Ethical guidelines have required them
to offer modest support to identified women in the com-
parison arm. There is growing evidence that simply ask-
ing women about IPV can result in a Hawthorne effect;
raising the level of consciousness of some women from
pre-contemplation to contemplation, or even a higher
level of action [11]. The investigators recognised that
women identified as experiencing IPV in the comparison
arm might have acted on the resources offered and
sought help, thus attenuating the effect of the interven-
tion. The need to investigate such impacts adds to the
growing arguments for process evaluations to illuminate
the aspects of a healthcare intervention that have the
greatest effects on the outcome [4, 12].
Advancing this complex field of healthcare interven-
tions also argues for longer-term follow-up of both
women and providers to see whether there is sustained
provider behaviour change and whether the ‘seed’
planted in the woman’s mind at the time of intervention
might have germinated after 24 or 36 months (if not im-
mediately). Gupta et al. recommend such work, which
must also explore factors beyond the individual provider
and the woman, and investigate the organisational and
systems changes that may have been important at differ-
ent levels of the healthcare system to support a wider
and more integrated systems-wide response to IPV.
Interventions for IPV in healthcare settings are com-
plex and require a sound theoretical basis to explain
their hypotheses or logic models and to promote their
implementation and sustainability. Healthcare providers
work in complex systems and hierarchies, and specific
adjustments may be required within the organisation
and management structure to integrate IPV interven-
tions and sustain changes in work practices [13, 14].
Coordinating and integrating strategies between and
among all levels of a healthcare system are crucial to ef-
fective responses in health system interventions in LMI
countries, irrespective of their entry point in primary or
tertiary care [15]. Leaders, managers and advocates for
improved responses to IPV are also important for enab-
ling change [12]. Intervention development in LMI
countries must also account for the presence or absence
of ongoing structural support services outside the
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facility, including community-based resources, non-
governmental organisations, legal frameworks and well-
trained police. All of these are vital to offer long-term
support and to understand the potential to maximise
healthcare system and providers’ confidence and ability
to support women [16].
Conclusions
It is critical to understand the broader systems context in
which healthcare interventions operate in LMI countries
(which is relevant also for adaptation and scaling up), as
the focus of previous studies has primarily been on the ef-
fectiveness of the intervention rather than the processes of
adaptation, coordination and integration. We strongly rec-
ommend long-term intervention trials that follow women
beyond the healthcare setting, to understand their coping
mechanisms and use or non-use of the formal and infor-
mal support services available in their communities. As
we have done in healthcare interventions in high income
countries, we also recommend theory-driven investigation,
including a strong focus on the sustainability of healthcare
system responses and healthcare provider interventions in
LMI countries [17, 18]. Comprehensive understanding of
flexible, low-cost, high impact interventions in LMI countries
is critical to ensure that the healthcare system is effective in
improving the safety and lives of women and children in
families exposed to IPV, and preventing their deaths.
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